skip to Main Content

FAM172A Inhibits EMT in Pancreatic Cancer via ERK-MAPK Signaling

FAM172A Inhibits EMT in Pancreatic Cancer via ERK-MAPK Signaling
FAM172A, as a newly discovered gene, is little known in cancer development, especially in pancreatic cancer (PC). We investigated the potential role and molecular mechanism of FAM172A in epithelial to mesenchymal transition (EMT) in both human clinical samples and PC cells.

FAM172A was downregulated in human PC tissues compared with that in non-cancerous pancreas cells by immunohistochemistry and qRT-PCR. FAM172A expression was negatively associated with tumor size (P=0.015), T stage (P=0.006), lymph node metastasis (P=0.028) and the worst prognosis of PC patients (P=0.004). Read more . . . 


Back To Top